Cargando…

Growth regulation and steroid hormone resistance in breast cancer

Detalles Bibliográficos
Autor principal:	Horwitz, KB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300831/ http://dx.doi.org/10.1186/bcr132

Ejemplares similares

Steroid regulation of breast cancer cell proliferation
por: Sutherland, RL
Publicado: (2003)

Hormones and radiation as risk factors for breast cancer
por: Beral, V
Publicado: (2006)

Combined hormonal therapy for advanced breast cancer in postmenopausal patients
por: Langecker, P, et al.
Publicado: (2003)

Placental hormones and the control of fetal growth
por: Freemark, Michael
Publicado: (2015)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

How safe is growth hormone treatment during childhood?
por: Cutfield, Wayne
Publicado: (2013)

Surviving starvation: essential role of the ghrelin-growth hormone axis
por: Goldstein, Joseph L, et al.
Publicado: (2012)

How safe is growth hormone therapy? SAGhE and beyond
por: Carel, Jean-Claude
Publicado: (2013)

Growth hormone responsiveness: why does it vary and can it be predicted?
por: Cutfield, Wayne S
Publicado: (2015)

Effect of growth hormone on bone fragility in patients with Prader-Willi syndrome scoliosis
por: Nakamura, Yutaka, et al.
Publicado: (2015)

Insulin resistance in breast cancer: relevance and clinical implications
por: Goodwin, PJ
Publicado: (2011)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Response to low dose growth hormone treatment in infants and toddlers with Prader-Willi Syndrome
por: Scheermeyer, Elly, et al.
Publicado: (2015)

Response to growth hormone therapy and gonadal pathology in 45,X/46,XY females
por: Titmuss, Angela, et al.
Publicado: (2015)

Regulation of growth and metabolism
por: Sabatini, David M
Publicado: (2014)

Risk of osteoporotic fracture after steroid injections in Medicare patients
por: Carreon, Leah, et al.
Publicado: (2014)

Microarray studies reveal novel genes associated with endocrine resistance in breast cancer
por: Burmi, RS, et al.
Publicado: (2006)

Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis
por: Henry, LA, et al.
Publicado: (2010)

The need for a cultural shift from two-arm to multi-arm RCTS
por: Sydes, Matthew R, et al.
Publicado: (2013)

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy
por: Roy, R, et al.
Publicado: (2010)

BRCA1 transcriptionally regulates genes associated with the basal breast cancer phenotype
por: Quinn, JE, et al.
Publicado: (2006)

Regulation of recombinational repair by the familial breast cancer susceptibility protein BRCA2
por: West, SC, et al.
Publicado: (2006)

Regulation of human breast stem cells
por: Clarke, RB
Publicado: (2006)

Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer
por: Klijn, JGM, et al.
Publicado: (2005)

Regulation of vascular growth and tone by hydrogen sulfide
por: Papapetropoulos, Andreas
Publicado: (2011)

A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011)

Off-pump coronary revascularization performed concomitant with non-cardiovascular surgery
por: Han, JW, et al.
Publicado: (2013)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
por: Wakefield, LM, et al.
Publicado: (2003)

Excess body weight, diabetes and cancer: epidemiologic evidence implicating hormonal and metabolic mechanisms
por: Kaaks, Rudolf
Publicado: (2012)

The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
por: Aloia, Andrea, et al.
Publicado: (2015)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Preoperative hormonal therapy: results and implications
por: Dowsett, M
Publicado: (2005)

Epigenetics of breast cancer
por: Esteller, M
Publicado: (2011)

Long Term Mortality in Critically Ill Burn Survivors
por: Nitzschke, SL, et al.
Publicado: (2015)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Long-term survival of interval breast cancers in breast cancer screening in Wales
por: Fong, YF, et al.
Publicado: (2012)

Imaging angiogenesis in early stages of breast cancer using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor
por: Mandl, S, et al.
Publicado: (2003)

Hormonal interactions during mammary gland development
por: Vonderhaar, BK
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_pditidu87s4l116nfqqsos23e1